Skip to content
Open access · OA via OpenAlex

Glutathione dysregulation and the etiology and progression of human diseases

Nazzareno Ballatori, Suzanne M. Krance, Sylvia Notenboom, Shujie Shi, Kim Tieu, Christine L. Hammond

Biological Chemistry · 2009 · ▲ 1,122 citations

Abstract

Glutathione (GSH) plays an important role in a multitude of cellular processes, including cell differentiation, proliferation, and apoptosis, and as a result, disturbances in GSH homeostasis are implicated in the etiology and/or progression of a number of human diseases, including cancer, diseases of aging, cystic fibrosis, and cardiovascular, inflammatory, immune, metabolic, and neurodegenerative diseases. Owing to the pleiotropic effects of GSH on cell functions, it has been quite difficult to define the role of GSH in the onset and/or the expression of human diseases, although significant progress is being made. GSH levels, turnover rates, and/or oxidation state can be compromised by inherited or acquired defects in the enzymes, transporters, signaling molecules, or transcription factors that are involved in its homeostasis, or from exposure to reactive chemicals or metabolic intermediates. GSH deficiency or a decrease in the GSH/glutathione disulfide ratio manifests itself largely through an increased susceptibility to oxidative stress, and the resulting damage is thought to be involved in diseases, such as cancer, Parkinson's disease, and Alzheimer's disease. In addition, imbalances in GSH levels affect immune system function, and are thought to play a role in the aging process. Just as low intracellular GSH levels decrease cellular antioxidant capacity, elevated GSH levels generally increase antioxidant capacity and resistance to oxidative stress, and this is observed in many cancer cells. The higher GSH levels in some tumor cells are also typically associated with higher levels of GSH-related enzymes and transporters. Although neither the mechanism nor the implications of these changes are well defined, the high GSH content makes cancer cells chemoresistant, which is a major factor that limits drug treatment. The present report highlights and integrates the growing connections between imbalances in GSH homeostasis and a multitude of human diseases.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1515/bc.2009.033
Canonical
link ↗
Fetched
2026-07-29 MST

Cite this

APA
Ballatori, N., Krance, S.M., Notenboom, S., Shi, S., Tieu, K., &amp; Hammond, C.L. (2009). Glutathione dysregulation and the etiology and progression of human diseases. <em>Biological Chemistry</em>. https://doi.org/10.1515/bc.2009.033
Vancouver
Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL. Glutathione dysregulation and the etiology and progression of human diseases. Biological Chemistry. 2009. doi:10.1515/bc.2009.033.
BibTeX
@article{nazzareno2009Glutat, title = {Glutathione dysregulation and the etiology and progression of human diseases}, author = {Nazzareno Ballatori and Suzanne M. Krance and Sylvia Notenboom and Shujie Shi and Kim Tieu and Christine L. Hammond}, journal = {Biological Chemistry}, year = {2009}, doi = {10.1515/bc.2009.033}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings